Targeting DNA Damage Response-Mediated Resistance in Non-Small Cell Lung Cancer: From Mechanistic Insights to Drug Development
Non-small cell lung cancer (NSCLC) remains a major contributor to cancer-related deaths worldwide, with therapeutic resistance presenting a critical clinical hurdle. The DNA damage response (DDR) constitutes a sophisticated cellular framework that detects, signals, and repairs genetic lesions to pre...
Saved in:
Main Authors: | Xue Gong, Yongzhao Zhou, Yi Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/32/7/367 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small-cell lung cancer
by: Nicolay G. Bakhmutsky, et al.
Published: (2017-12-01) -
Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents
by: Anne C. Chiang, MD, PhD, et al.
Published: (2025-09-01) -
Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
by: Ayako Nawashiro, et al.
Published: (2022-01-01) -
THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
by: E. P. Solov’eva, et al.
Published: (2016-02-01) -
FACTORS OF TREATMENT EFFIENCY OF INOPERABLE STAGE III NON-SMALL CELL LUNG CANCER (REVIEW OF LITERATURE)
by: E. P. Solovyeva, et al.
Published: (2016-07-01)